Cargando…
Systematic Review and Network Meta-Analysis of Immune Checkpoint Inhibitors in Combination with Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Carcinoma
SIMPLE SUMMARY: Patients with extensive-stage small cell lung cancer (ED-SCLC) have a very short survival time even if they receive standard chemotherapy. Currently, the combination of chemotherapy plus immune checkpoint inhibitors (ICIs) as the first line treatment had superior survival than chemot...
Autores principales: | Chen, Hsiao-Ling, Tu, Yu-Kang, Chang, Hsiu-Mei, Lee, Tai-Huang, Wu, Kuan-Li, Tsai, Yu-Chen, Lee, Mei-Hsuan, Yang, Chih-Jen, Hung, Jen-Yu, Chong, Inn-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761843/ https://www.ncbi.nlm.nih.gov/pubmed/33287455 http://dx.doi.org/10.3390/cancers12123629 |
Ejemplares similares
-
First-Line Anaplastic Lymphoma Kinase (ALK) Inhibitors for ALK-Positive Lung Cancer in Asian Populations: Systematic Review and Network Meta-Analysis
por: Wu, Kuan-Li, et al.
Publicado: (2021) -
Salvage Therapy for Relapsed Malignant Pleural Mesothelioma: A Systematic Review and Network Meta-Analysis
por: Tsai, Yu-Chen, et al.
Publicado: (2021) -
Better Progression-Free Survival in Elderly Patients with Stage IV Lung Adenocarcinoma Harboring Uncommon Epidermal Growth Factor Receptor Mutations Treated with the First-line Tyrosine Kinase Inhibitors
por: Tsai, Ming-Ju, et al.
Publicado: (2018) -
Local Consolidative Therapy May Have Prominent Clinical Efficacy in Patients with EGFR-Mutant Advanced Lung Adenocarcinoma Treated with First-Line Afatinib
por: Tsai, Ming-Ju, et al.
Publicado: (2023) -
The Factors Predicting Concordant Epidermal Growth Factor Receptor (EGFR) Mutation Detected in Liquid/Tissue Biopsy and the Related Clinical Outcomes in Patients of Advanced Lung Adenocarcinoma with EGFR Mutations
por: Kuo, Chia-Yu, et al.
Publicado: (2019)